Other Events ·
On June 17, 2026, Serina Therapeutics, Inc. filed a certificate of amendment to its Certificate of Incorporation to…
SERSerina Therapeutics, Inc.
On June 17, 2026, Serina Therapeutics, Inc. filed a certificate of amendment to its Certificate of Incorporation to increase the number of authorized shares of common stock from 40,000,000 to 125,000,000. At its 2026 Annual Meeting, stockholders also approved increasing the 2024 Equity Incentive Plan by 2,000,000 shares, the conversion of certain Series A Preferred Stock into common stock, and the exercise of certain Private Placement Securities into common stock. The company operates in the biotechnology industry and develops therapeutic products.